Cosep, Kyra Kloe A.
HRN: 21-34-76 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/25/2022
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
05/25/2022
05/29/2022
IV
35mg
Q24h
Neonatal Sepsis
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Guideline Not Available
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes